NAD Atlas
Explore by ingredientNAD+NRNMNCompare providers

Gala review

An asynchronous injection service with automatic refills and quarterly check-ins.

We may earn a commission from partner links. Our reviews cover both partners and other providers. How we are funded

Where it fits

Its appointment model is clear; the annual price needs a total-cost comparison.

Reasons to consider it

  • Async review described
  • Visit and shipping included in offer

Worth a closer look

  • 28-day supply differs from calendar month
  • Annual-plan headline conceals a larger commitment

No scheduled video visit

Gala describes an online intake reviewed asynchronously by a licensed provider. Home injections follow only if prescribed.

This suits a reader comparing appointment logistics, though follow-up access still deserves a question.

Two different commitments

The page advertises $199 for a 28-day supply and a lower monthly-style figure on a 12-month plan.

Ask for the total annual charge and cancellation consequences before choosing the lower number.

Refills are part of the plan

Gala describes automatic refills and quarterly check-ins. It says an unsuitable prescription decision triggers a full refund.

Clarify how renewal reminders work and when you must act to stop future shipments.

What to ask before committing

Confirm the full amount due today, renewal terms, and any required consultation, laboratory, medication, supply or shipping fees. Check availability where you live and how you can reach support after signing up.

For prescription care, ask who will evaluate you and which pharmacy would dispense your medication. A provider comparison cannot determine whether a treatment is appropriate for you.

Put the details in context

Compare ingredients and formats Build a cost worksheet Read the research

This is an editorial assessment of published provider information, not a patient testimonial. Offers and availability can change. See our editorial standards.

Before you go

One more option to compare.

We may earn a commission from the partner below. It is a separate provider, and eligibility and treatment decisions require its own evaluation.

Explore partner Continue to your provider